AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 20,000 | +5.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 18,900 | -45.8% | 0.00% | -100.0% |
| Q1 2022 | $17,000 | +325.0% | 34,900 | -3.9% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 36,300 | +16.7% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 31,100 | +14.8% | 0.00% | – |
| Q3 2020 | $5,000 | -95.0% | 27,100 | +68.3% | 0.00% | -100.0% |
| Q2 2020 | $101,000 | +288.5% | 16,100 | +56.3% | 0.01% | +500.0% |
| Q4 2019 | $26,000 | 0.0% | 10,300 | -15.6% | 0.00% | -50.0% |
| Q3 2018 | $26,000 | -33.3% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $39,000 | +387.5% | 12,200 | +16.2% | 0.00% | – |
| Q4 2017 | $8,000 | – | 10,500 | +5.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |